Iran’s leadership has repeatedly affirmed its right to uranium enrichment for civilian purposes under the Nuclear Non-Proliferation Treaty, with recent diplomatic signals focused on stockpile management—such as dilution or third-party transfer of 60 percent enriched material—rather than a complete halt to all enrichment activities. Ongoing talks with the United States emphasize sequencing disputes, where Tehran seeks sanctions relief and inspector access concessions before deeper nuclear limits, and domestic statements reject zero-enrichment demands. These positions, reinforced by stalled negotiations and IAEA compliance concerns through September 2026, underpin trader consensus against a full agreement by October 31. A breakthrough would require rapid US sanctions relief or verified commitments that override current red lines, though such shifts remain unlikely within the short window absent major diplomatic reversals.